I hope this letter will give you a sense of our Yongye's development
and our strategic direction. We look forward to updating you on events
through earnings conference calls, press releases, our filings with the
Securities and Exchange Commission and visits to meet with investors and
the financial community. I would like to thank our customers, shareholders,
directors and employees for the Company's present and future success.
Thank you for your interest in Yongye.
Mr. Zishen Wu
CEO and Chairman of the Board
Yongye Biotechnology International, Inc.
About Yongye Biotechnology International, Inc.
Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the development, distribution and sales of fulvic acid based nutrients for plants and animals. The Company's patent pending processes and proprietary formulas allow it to create products which increase crop yields and improve the health of livestock. Its sole operating subsidiary, Yongye Nongfeng Biotechnology Company, Ltd., is located in Inner Mongolia. The Company sells its products through distributors and directly to farmers located in ten provinces throughout China.
Forward Looking Statements
Certain statements set forth in this press release constitute "Forward-
looking statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements include, without limitation
|SOURCE Yongye Biotechnology International, Inc.|
Copyright©2008 PR Newswire.
All rights reserved